NEW YORK, Aug. 26 (GenomeWeb News) - Third Wave Technologies and 3M today announced a supply pact that will enable Third Wave's customers the option of coupling the firm's Invader DNA and RNA analytical chemistry technology with 3M's microfluidics technology.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
